NFKB1 and neoplasm: RP-high genes originating from tumour cells were over-represented in immune signalling pathways (IL-17, NFkB, TNF) and drug metabolism (figure 3B), highlighting two plausible mechanisms (impaired immunogenic cell death, enhanced metabolic inactivation) undermining chemotherapy efficacy.16 25